Trials for vCJD treatment held up because of disagreementsBMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7423.1069 (Published 06 November 2003) Cite this as: BMJ 2003;327:1069
- Owen Dyer
Two years after the government announced urgent action to investigate possible treatments for variant Creutzfeldt-Jakob disease (vCJD), trials are still being held up because experts are unable to agree which drugs should be studied.
Professor Iain Chalmers, who heads the steering committee appointed to design the clinical trials, has told the patients' families to complain to their MPs about the delay. At a meeting of the CJD Support Network two weeks ago, Professor Chalmers said: “Families of patients who have suffered or are suffering from …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial